Join the BioFabUSA technology team members on Wednesday, September 14th from 3:30-5:30 pm at the Biomedical Manufacturing For Warfighter Treatment Needs Session.
Dr. Mary Clare McCorry, BioFab’s Director of Technology and Process Development is presenting Transforming Manufacturing Technologies to Achieve Scalable, Consistent, Cost-effective Production of Cell and Tissue Therapies, and Associate Scientist Sarah Piet will present Enabling the Scalable Modular Automated and Closed Manufacturing of the Tissue Engineered Muscle Repair (TEMR) Product for Use in Volumetric Muscle Loss (VML.)
The MHSRS is the Department of Defense’s foremost scientific meeting. It provides a venue for presenting new scientific knowledge resulting from military-unique research and development. The MHSRS is the premier military or civilian meeting that focuses specifically on the unique medical needs of the Warfighter.
The MHSRS provides a collaborative setting for the exchange of information between military providers with deployment experience, research and academic scientists, international partners, and industry on research and related health care initiatives falling under the topic areas of Combat Casualty Care, Military Operational Medicine, Clinical and Rehabilitative Medicine, Medical Simulation and Information Sciences, Military Infectious Diseases, and the Radiation Health Effects.
The MHSRS is an annual four-day educational symposium that draws approximately 3,500 attendees.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
